237 related articles for article (PubMed ID: 32333138)
1. 'Good cancer gone bad': a narrative review of HPV oropharyngeal cancer and potential poor outcomes.
Alabi O; O'Neill JP
Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2185-2191. PubMed ID: 32333138
[TBL] [Abstract][Full Text] [Related]
2. Oropharyngeal cancer - is it time to change management according to human papilloma virus status?
Mehanna H; Olaleye O; Licitra L
Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):120-4. PubMed ID: 22327790
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
[TBL] [Abstract][Full Text] [Related]
4. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
[TBL] [Abstract][Full Text] [Related]
5. Cancer of the Oropharynx and the Association with Human Papillomavirus.
Rettig EM; Sethi RKV
Hematol Oncol Clin North Am; 2021 Oct; 35(5):913-931. PubMed ID: 34244016
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
7. Management of Oropharyngeal Cancer in the HPV Era.
Naghavi AO; Strom TJ; Ahmed KA; Echevarria MI; Abuodeh YA; Venkat PS; Frakes JM; Harrison LB; Trotti AM; Caudell JJ
Cancer Control; 2016 Jul; 23(3):197-207. PubMed ID: 27556659
[TBL] [Abstract][Full Text] [Related]
8. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
[TBL] [Abstract][Full Text] [Related]
9. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
[TBL] [Abstract][Full Text] [Related]
10. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.
Rettig EM; Zaidi M; Faraji F; Eisele DW; El Asmar M; Fung N; D'Souza G; Fakhry C
Oral Oncol; 2018 Aug; 83():147-153. PubMed ID: 30098771
[TBL] [Abstract][Full Text] [Related]
11. Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer.
Hanna GJ; Lau CJ; Mahmood U; Supplee JG; Mogili AR; Haddad RI; Jänne PA; Paweletz CP
Oral Oncol; 2019 Aug; 95():120-126. PubMed ID: 31345379
[TBL] [Abstract][Full Text] [Related]
12. Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
Dahlstrom KR; Li G; Hussey CS; Vo JT; Wei Q; Zhao C; Sturgis EM
Cancer; 2015 Oct; 121(19):3455-64. PubMed ID: 26094818
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus-associated oropharynx cancer (HPV-OPC): treatment options.
Chau NG; Rabinowits G; Haddad RI
Curr Treat Options Oncol; 2014 Dec; 15(4):595-610. PubMed ID: 25240410
[TBL] [Abstract][Full Text] [Related]
14. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer.
Huang SH; Perez-Ordonez B; Weinreb I; Hope A; Massey C; Waldron JN; Kim J; Bayley AJ; Cummings B; Cho BC; Ringash J; Dawson LA; Siu LL; Chen E; Irish J; Gullane P; Hui A; Liu FF; Shen X; Xu W; O'Sullivan B
Oral Oncol; 2013 Jan; 49(1):79-85. PubMed ID: 22917550
[TBL] [Abstract][Full Text] [Related]
15. Postoperative Treatment of Oropharyngeal Cancer in the Era of Human Papillomavirus.
Geiger JL; Ku JA
Curr Treat Options Oncol; 2019 Feb; 20(3):20. PubMed ID: 30771020
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
[TBL] [Abstract][Full Text] [Related]
17. Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
Ho AS; Luu M; Kim S; Tighiouart M; Mita AC; Scher KS; Mallen-St Clair J; Walgama ES; Lin DC; Nguyen AT; Zumsteg ZS
Cancer; 2021 May; 127(10):1590-1597. PubMed ID: 33595897
[TBL] [Abstract][Full Text] [Related]
18. Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study.
Lefevre M; Rousseau A; Rayon T; Dalstein V; Clavel C; Beby-Defaux A; Pretet JL; Soussan P; Polette M; Lacau Saint Guily J; Birembaut P;
Br J Cancer; 2017 Jan; 116(3):362-369. PubMed ID: 28072763
[TBL] [Abstract][Full Text] [Related]
19. A cross-sectional survey of awareness of human papillomavirus-associated oropharyngeal cancers among general practitioners in the UK.
Lechner M; Vassie C; Kavasogullari C; Jones O; Howard J; Masterson L; Fenton T; Yarbrough W; Waller J; Gilson R
BMJ Open; 2018 Jul; 8(7):e023339. PubMed ID: 30056394
[TBL] [Abstract][Full Text] [Related]
20. HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.
Maxwell JH; Grandis JR; Ferris RL
Annu Rev Med; 2016; 67():91-101. PubMed ID: 26332002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
